Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Minoxidil can cause deadly skin reaction; monitor patients closely.